Delivery Order SPE2DX15D2003-SPE2DX24F5AJ2
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,288.54 firm fixed-price contract is for the delivery of 40,000 units/mL of the drug PROCRIT, with a completion date of March 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,666.43 contract is for the delivery of 40,000 units/mL vials of the pharmaceutical product PROCRIT. The delivery order has a completion date of January 24, 2024 and was awarded on January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division,...
- The U.S. government agency Medical Supply Chain, which is part of the Defense Logistics Agency (DLA), awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $1,307.36 and is for the delivery of 20,000 units/mL vials of PROCRIT, a medication used to treat anemia. The contract has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is also the prime contractor on...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,348.46 contract is for the supply of 20,000 units of the medication PROCRIT (2 mL vials) with a completion date of May 19, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10,000 units of Procrit (Epoetin alfa) 10,000 units/mL vials. The $2,273.25 firm-fixed-price contract has an ultimate completion date of August 16, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the procurement of 10,000 units of the pharmaceutical product PROCRIT 10,000 UNITS/ML VIALML. The order has a ceiling value of $2,087.69 and is a firm fixed-price contract. The period of performance runs through July 15, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, with a focus on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Procrit 40,000 units/ml vials, a pharmaceutical product used in treating anemia and related conditions. This firm fixed-price delivery order has a ceiling value of $4,092.76 and is scheduled for completion by August 8, 2025. The contract is not set-aside and represents a competitive award to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,784.99 delivery order is for the supply of 10,000 units/ml of the drug Procrit. This award does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,976.20 firm fixed price delivery order is for the supply of EPOGEN 20,000 units/mL vials, a specialty pharmaceutical product. The contract does not utilize any set-aside designations and has a completion date of February 26, 2024. AmerisourceBergen Drug Corp,...
- SPE2DX15D2003Indefinite Delivery Contract
- SPE2DX15D2003-SPE2DX24F5AJ2Delivery Order
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a potential value of $2,060.80 and a completion date of January 26, 2024. It is for the delivery of 40,000 units/mL of PROCRIT, a pharmaceutical product, to a location in Conshohocken, Pennsylvania. This award is issued under a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, valued at up to $999,999,999.00 and with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/25/24 |